All Stories

  1. The Evolving Field of Risk Communication
  2. Pharmaceutical Benefit–Risk Perception and Age Differences in the USA and Germany
  3. COVID-19: Reflections on trust, tradeoffs, and preparedness
  4. Effects of public trust on behavioural intentions in the pharmaceutical sector: data from six European countries
  5. Pharmaceutical Benefit-Risk Perception and Older Age: A Pilot Study
  6. Pharmaceutical Benefit–Risk Communication Tools: A Review of the Literature
  7. Medicines transparency at the European Medicines Agency (EMA) in the new information age: the perspectives of patients
  8. Transparency of medicines data and safety issues–a European/US study of doctors’ opinions: what does the evidence show?
  9. Transparency in Europe: A Quantitative Study
  10. Transparency and trust in the European pharmaceutical sector: a Commentary
  11. Transparency and trust in the European pharmaceutical sector: outcomes from a qualitative study